CEP19
Centrosomal protein of 19 kDa
Also known as: C3orf34, CEP19_HUMAN, MGC14126
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96LK0
- Gene
- CEP19
- Ensembl
- ENSG00000174007
- Chromosome
- 3
- Canonical length
- 163 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome,Basal body,Cytosol
OverviewNCBI Gene
The protein encoded by this gene localizes to centrosomes and primary cilia and co-localizes with a marker for the mother centriole. This gene resides in a region of human chromosome 3 that is linked to morbid obesity. A homozygous knockout of the orthologous gene in mouse resulted in mice with morbid obesity, hyperphagy, glucose intolerance, and insulin resistance. Mutations in this gene cause morbid obesity and spermatogenic failure (MOSPGF). This gene has a pseudogene on human chromosome 2. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
163 residues, UniProt reviewed canonical sequence.
>Q96LK0|CEP19
1 MMCTAKKCGI RFQPPAIILI YESEIKGKIR QRIMPVRNFS KFSDCTRAAE QLKNNPRHKS
61 YLEQVSLRQL EKLFSFLRGY LSGQSLAETM EQIQRETTID PEEDLNKLDD KELAKRKSIM
121 DELFEKNQKK KDDPNFVYDI EVEFPQDDQL QSCGWDTESA DEFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CEP19 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 9.3 nTPM
Expression across tissuesHPA
Tissue
- testis: 9.3 nTPM
- thymus: 7.1 nTPM
- cerebral cortex: 6.2 nTPM
- basal ganglia: 6.1 nTPM
- retina: 6.1 nTPM
- hypothalamus: 5.3 nTPM
Single-cell type
- late primary spermatocytes: 113 nCPM
- neutrophils: 87 nCPM
- differentiating spermatogonia: 51 nCPM
- early primary spermatocytes: 43 nCPM
- respiratory ciliated cells: 38 nCPM
- undifferentiated spermatogonia: 34 nCPM
Immune cell
- neutrophil: 144 nTPM
- eosinophil: 59 nTPM
- basophil: 51 nTPM
- plasmacytoid DC: 11 nTPM
- naive CD4 T-cell: 10 nTPM
- memory CD4 T-cell: 7.9 nTPM
Brain region
- hypothalamus: 8.8 nTPM
- choroid plexus: 8.4 nTPM
- cerebral cortex: 8.2 nTPM
- hippocampal formation: 7.7 nTPM
- midbrain: 7.7 nTPM
- white matter: 7.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CEP19.
Disease | AllUniProt
Conditions CEP19 is implicated in, by any mechanism.
- Morbid obesity and spermatogenic failure (MOSPGF) MIM:615703
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 117 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0.02
- gnomAD missense Z
- -0.14
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- microtubule anchoring at centrosome
- vesicle targeting, trans-Golgi to periciliary membrane compartment
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Centrosomal protein of 19kDa
- CEP19-like protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CEP19 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CEP19 as an antibody target. Whether an autoantibody or antibody against CEP19 could matter depends on whether native CEP19 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CEP19 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CEP19 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...